The legal action, initiated by The Gross Law Firm, follows a sharp downturn in Embecta’s market value. On May 5, 2026, the company reported second-quarter results that fell significantly short of projections, revealing a revenue decline exceeding 14%. This disclosure contradicted previous corporate guidance, which had suggested performance would remain flat or see only a marginal dip.

The market reaction was immediate and severe. Embecta’s stock price plummeted from a closing value of $9.25 on May 4 to $3.90 the following day, marking a single-day loss of more than 57%. The complaint alleges that management knew or recklessly disregarded that their financial forecasts were unattainable while publicly describing the company's pen needle division as incredibly resolute. Affected shareholders seeking to participate as lead plaintiffs must register their claims before the August 17 deadline.